Senior Director, Global Medical Neuroscience, Psychiatry, Mood Disorders
Bristol Myers Squibb
Summary
The Senior Director, Global Medical Neuroscience, Psychiatry, Mood Disorders will serve as a senior medical and scientific leader responsible for shaping and driving the global medical strategy for BMS's Mood Disorders portfolio. This role will provide strategic direction and leadership across the full lifecycle of asset development and commercialization, while fostering deep cross-functional collaboration with key stakeholders, including US and WW Commercial, Research and Development, Global Drug Development, HEOR, Regulatory Affairs, and global medical stakeholders. The Senior Director will partner closely with the Associate Director, WW Medical Strategy, Psychiatry to support execution of Mood Disorders medical activities, build and lead a high-performing medical team, shape the Mood Disorders medical vision, and represent BMS externally as a senior scientific ambassador. This position reports to the Executive Director, Mood Disorders, Medical Product Lead, Global Medical Neuroscience, Psychiatry.
Job description
Position Summary
The Senior Director, Global Medical Neuroscience, Psychiatry, Mood Disorders will serve as a senior medical and scientific leader responsible for shaping and driving the global medical strategy for BMS's Mood Disorders portfolio. This role will provide strategic direction and leadership across the full lifecycle of asset development and commercialization, while fostering deep cross-functional collaboration with key stakeholders, including US and WW Commercial, Research and Development, Global Drug Development, HEOR, Regulatory Affairs, and global medical stakeholders. The Senior Director will partner closely with the Associate Director, WW Medical Strategy, Psychiatry to support execution of Mood Disorders medical activities, build and lead a high-performing medical team, shape the Mood Disorders medical vision, and represent BMS externally as a senior scientific ambassador. This position reports to the Executive Director, Mood Disorders, Medical Product Lead, Global Medical Neuroscience, Psychiatry.
Strategic Leadership & Medical Strategy
- Define, lead, and oversee the development, implementation, and execution of the global Mood Disorders medical strategy, ensuring full alignment with BMS enterprise objectives and portfolio priorities.
- Serve as the senior medical representative in high-level strategic and cross-functional forums, shaping the direction of the Mood Disorders program from early development through commercialization.
- Lead the Medical Matrix Team, driving the creation and execution of a comprehensive, integrated Medical Plan aligned with disease area and product strategies.
- Anticipate and translate the rapidly evolving Mood Disorders treatment landscape — including competitive intelligence, emerging science, and regulatory trends — into actionable medical strategies.
- Provide strategic input into pipeline prioritization, asset development decisions, and lifecycle management for Mood Disorders assets.
Cross-Functional & Stakeholder Collaboration
- Act as a senior strategic partner across Commercial, Market Access, Regulatory, R&D, and HEOR functions, ensuring medical perspectives are fully integrated into Brand Planning, launch readiness, and commercialization strategies.
- Represent Medical Strategy at the highest levels of cross-functional brand teams, contributing to portfolio-level decisions and enterprise planning processes.
- Collaborate with Commercialization & Access organizations to integrate medical perspectives and ensure strong alignment between commercial and medical plans globally.
- Coordinate with Marketing and matrix partners to communicate results from clinical trials, treatment guidelines, and other clinical data internally and externally.
Partnership with WW Medical Strategy
- Partner closely with, provide strategic direction to, and support the development of the Associate Director, WW Medical Strategy, Psychiatry, ensuring alignment on Mood Disorders medical priorities and consistent execution of the Medical Plan.
- Delegate and oversee execution of key medical activities — including Thought Leader engagement, advisory boards, congress support, and publications — in partnership with the Associate Director and broader WW Medical Strategy team.
- Create clarity on ownership, decision rights, and escalation pathways between Senior Director-level strategy and Associate Director-level execution to ensure efficient, well-coordinated delivery of the Mood Disorders medical plan.
- Review and provide guidance on deliverables produced by the Associate Director and WW Medical Strategy team, ensuring quality, scientific rigor, and strategic alignment.
External Engagement & Scientific Leadership
- Cultivate and maintain senior-level relationships with global thought leaders, key opinion leaders, academic centers, clinical researchers, and patient advocacy organizations within the Mood Disorders space.
- Serve as a senior external-facing representative of BMS, presenting scientific data and strategy at major medical congresses, advisory boards, and scientific forums.
- Lead the strategy for Thought Leader identification, mapping, profiling, and engagement, driving a differentiated approach for the Mood Disorders franchise.
- Oversee and support BMS-sponsored clinical and non-registrational research activities, including the design and execution of real-world evidence generation strategies.
People Leadership & Organizational Development
- Lead, mentor, and develop a team of medical professionals, fostering a high-performance, inclusive, and collaborative culture.
- Provide coaching, performance management, and development planning to direct reports across a multicultural, matrixed environment.
- Build organizational capability by identifying talent needs and championing team development initiatives.
- Model and champion BMS Values and the highest standards of scientific integrity in all activities.
Operational & Compliance Excellence
- Partner with stakeholders on medical activities including labeling, safety surveillance, scientific advisory boards, congress support, real-world data generation, and publications, ensuring the highest quality deliverables.
- Participate in decision-making relevant to selecting external organizations and researchers for research collaborations.
- Complete all assigned SOPs and training within designated timeframes and adhere to job-specific SOPs and work instructions.
- Conduct all business in accordance with BMS Values and relevant compliance standards.
Qualifications & Experience
Education: Advanced degree (PhD, MD, DO, NP, PA, PharmD, etc.) in a scientific discipline, or an equivalent combination of education and experience. MD or PhD strongly preferred.
Experience: A minimum of 10+ years of progressive professional experience in pharmaceutical development within life sciences or biopharmaceuticals, with a demonstrated track record of increasing strategic and leadership responsibility. Minimum 5 years of medical affairs (WW or US) experience specific to Psychiatry or Mood Disorders.
Industry Knowledge: Deep understanding of the biopharma drug development and commercialization process. Experience in clinical research, development, or medical affairs in Psychiatry, with Mood Disorders experience strongly preferred.
Leadership: Demonstrated ability to lead at a senior level — driving strategic vision, building organizational alignment, managing and developing teams, and influencing senior enterprise stakeholders in a matrixed environment.
Strategic Thinking: Proven strength in synthesizing complex scientific and business information to develop overarching strategies, framing clearly differentiated choices, and driving decisions with enterprise-level impact.
Global Experience: Significant US and/or global medical affairs or clinical development experience is required.
Cross-Functional Experience: Extensive experience working across a range of medical, commercial, regulatory, and clinical development functions, with a demonstrated ability to lead enterprise-wide initiatives.
Analytical Skills: Advanced experience in analytics, data interpretation, and evidence generation, particularly in relation to asset launches and real-world evidence strategies.
Project & Portfolio Management: Strong experience managing complex, multi-stakeholder projects and portfolios, with a proven ability to develop and execute clear strategic action plans.
Interpersonal Skills: Exceptional ability to build relationships, influence and inspire at all organizational levels, and navigate complex organizational dynamics with credibility and integrity.
Communication: Outstanding written and verbal communication skills, including the ability to present complex scientific and strategic content to senior executive audiences and external stakeholders.
People Management: Proven track record of effective people leadership — including coaching, motivating, and development planning — in a multicultural, global environment.
Travel: Ability and willingness to travel globally (frequent international travel will be required).
Requirements
- Advanced degree (PhD, MD, DO, NP, PA, PharmD, etc.) in a scientific discipline, or an equivalent combination of education and experience
- MD or PhD strongly preferred
- Minimum of 10+ years of progressive professional experience in pharmaceutical development within life sciences or biopharmaceuticals
- Minimum 5 years of medical affairs (WW or US) experience specific to Psychiatry or Mood Disorders
- Deep understanding of the biopharma drug development and commercialization process
- Experience in clinical research, development, or medical affairs in Psychiatry, with Mood Disorders experience strongly preferred
- Demonstrated ability to lead at a senior level — driving strategic vision, building organizational alignment, managing and developing teams, and influencing senior enterprise stakeholders in a matrixed environment
- Proven strength in synthesizing complex scientific and business information to develop overarching strategies, framing clearly differentiated choices, and driving decisions with enterprise-level impact
- Significant US and/or global medical affairs or clinical development experience is required
- Extensive experience working across a range of medical, commercial, regulatory, and clinical development functions, with a demonstrated ability to lead enterprise-wide initiatives
- Advanced experience in analytics, data interpretation, and evidence generation, particularly in relation to asset launches and real-world evidence strategies
- Strong experience managing complex, multi-stakeholder projects and portfolios, with a proven ability to develop and execute clear strategic action plans
- Exceptional ability to build relationships, influence and inspire at all organizational levels, and navigate complex organizational dynamics with credibility and integrity
- Outstanding written and verbal communication skills, including the ability to present complex scientific and strategic content to senior executive audiences and external stakeholders
- Proven track record of effective people leadership — including coaching, motivating, and development planning — in a multicultural, global environment
- Ability and willingness to travel globally (frequent international travel will be required)
Benefits
- Wellbeing Support
- Retirement Benefits
- Financial Protection Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Flexible Time Off (FTO)
- 11 Paid Company Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Parental Leave
- Caregiver Leave
- Bereavement Leave
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.